(Q33921293)

30 July 2017

1 reference

title

Potential of substance P antagonists as antiemetics (English)

1 reference

30 July 2017

0 references

Diemunsch P

1

1 reference

PubMed ID

11030465

30 July 2017

Grélot L

series ordinal

2

1 reference

30 July 2017

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

60

1 reference

30 July 2017

533-546

1 reference

30 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060030-00002

30 July 2017

0 references

cites work

Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist

1 reference

12 December 2020

A neurokinin-1 receptor antagonist reduced hypersalivation and gastric contractility related to emesis in dogs.

1 reference

12 December 2020

The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis

1 reference

12 December 2020

Anti-emetic effects of a novel NK-1 receptor antagonist HSP-117 in ferrets.

1 reference

12 December 2020

GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity

1 reference

12 December 2020

Ethanol-induced emesis in the house musk shrew, Suncus murinus

1 reference

12 December 2020

The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.

1 reference

12 December 2020

The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040

1 reference

12 December 2020

Peptide-induced emesis in dogs

1 reference

12 December 2020

The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor

1 reference

12 December 2020

Neurochemistry of visceral afferent neurones.

1 reference

12 December 2020

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

1 reference

12 December 2020

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

1 reference

12 December 2020

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

1 reference

12 December 2020

Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171--PET studies in rhesus monkey

1 reference

12 December 2020

The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation

1 reference

12 December 2020

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

1 reference

12 December 2020

The substance P receptor antagonist CP-99,994 reduces acute postoperative pain

1 reference

12 December 2020

The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret

1 reference

12 December 2020

Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus

1 reference

12 December 2020

Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994

1 reference

12 December 2020

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets

1 reference

12 December 2020

GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions.

1 reference

12 December 2020

Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets

1 reference

12 December 2020

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor

1 reference

12 December 2020

Inhibition of anaesthetic-induced emesis by a NK1 or 5-HT3 receptor antagonist in the house musk shrew, Suncus murinus.

1 reference

12 December 2020

Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret

1 reference

12 December 2020

Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery.

1 reference

12 December 2020

Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet

1 reference

12 December 2020

The effect of CP-99994 on the responses to provocative motion in the cat.

1 reference

12 December 2020

The mammalian tachykinin receptors

1 reference

12 December 2020

Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994

1 reference

12 December 2020

Nonpeptide antagonists of the NK1 tachykinin receptor

1 reference

12 December 2020

The tachykinin NK1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs.

1 reference

12 December 2020

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.

1 reference

12 December 2020

Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor

1 reference

12 December 2020

Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis

1 reference

12 December 2020

Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret

1 reference

12 December 2020

Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils.

1 reference

12 December 2020

Capsaicin in the 4th ventricle abolishes retching and transmission of emetic vagal afferents to solitary nucleus neurons.

1 reference

12 December 2020

Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.

1 reference

12 December 2020

Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist

1 reference

12 December 2020

Organization of vestibular inputs to nucleus tractus solitarius and adjacent structures in cat brain stem

1 reference

12 December 2020

10.2165/00003495-200060030-00002

Identifiers

DOI

1 reference

PubMed ID

11030465

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

11030465